Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1027890 | 0.81 | NPC1 (0.31) | NPC1ALDH1A1RAB9A | |
| SCHEMBL7765530 | 0.77 | ALDH1A1 (0.31) | LMNANPC1ALDH1A1RAB9ANPSR1 | |
| SCHEMBL8372450 | 0.76 | SIGMAR1 (0.42) | LMNARECQLALDH1A1GAAP2RX7 | |
| SCHEMBL638296 | 0.76 | ALDH1A1 (0.44) | NPC1ALDH1A1RAB9AALOX12SMN1; SMN2 | |
| SCHEMBL6683632 | 0.71 | SMN1; SMN2 (0.32) | SMN1; SMN2 | |
| SCHEMBL26012913 | 0.71 | ESR1 (0.37) | LMNAALDH1A1GAANPSR1SMN1; SMN2 | |
| SCHEMBL1032197 | 0.70 | ALDH1A1 (0.35) | NPC1ALDH1A1RAB9AALOX12SMN1; SMN2 | |
| SCHEMBL1030258 | 0.70 | SCN10A (0.34) | NPC1ALDH1A1RAB9ANPSR1 | |
| SCHEMBL22648624 | 0.70 | ALDH1A1 (0.38) | LMNAALDH1A1 | |
| SCHEMBL27292055 | 0.67 | TXNRD1 (0.35) | ALDH1A1ALOX12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1474377-B1 | NITROSOPHENOLS AND C-NITROSOANILINES AS POLYMERIZATION INHIBITORS | CHEMTURA CORP (US) | 2011-01-19 | — | — | EP | claimed |
| US-7125475-B2 | Nitrosophenols and C-nitrosoanilines as polymerization inhibitors | CROMPTON CORPORATION (US) | 2006-10-24 | — | — | US | claimed |
| EP-1474377-A1 | NITROSOPHENOLS AND C-NITROSOANILINES AS POLYMERIZATION INHIBITORS | Crompton Corporation (US) | 2004-11-10 | — | — | EP | claimed |
| WO-2003070687-A1 | NITROSOPHENOLS AND C-NITROSOANILINES AS POLYMERIZATION INHIBITORS | CROMPTON CORPORATION (US) | 2003-08-28 | — | — | WO | claimed |
| US-20030155227-A1 | Nitrosophenols and C-nitrosoanilines as polymerization inhibitors | CROMPTON CORPORATION | 2003-08-21 | — | — | US | claimed |
| US-20180361319-A1 | METHOD FOR IMPROVED REACTVE MONOMER PRODUCTION WITH MEMBRANE FILTRATION | EVONIK DEGUSSA GMBH (DE) | 2018-12-20 | — | — | US | disclosed |
| EP-2993164-B1 | Phenolic (thio) acetals as inhibitors of the polymerisation of olefinically unsaturated monomers | EVONIK DEGUSSA GMBH (DE) | 2017-02-15 | — | — | EP | disclosed |
| EP-2993164-A1 | Phenolic (thio) acetals as inhibitors of the polymerisation of olefinically unsaturated monomers | Evonik Degussa GmbH (DE) | 2016-03-09 | — | — | EP | disclosed |
| EP-1474377-B1 | NITROSOPHENOLS AND C-NITROSOANILINES AS POLYMERIZATION INHIBITORS | CHEMTURA CORP (US) | 2011-01-19 | — | — | EP | disclosed |
| US-7125475-B2 | Nitrosophenols and C-nitrosoanilines as polymerization inhibitors | CROMPTON CORPORATION (US) | 2006-10-24 | — | — | US | disclosed |
| EP-1474377-A1 | NITROSOPHENOLS AND C-NITROSOANILINES AS POLYMERIZATION INHIBITORS | Crompton Corporation (US) | 2004-11-10 | — | — | EP | disclosed |
| WO-2003070687-A1 | NITROSOPHENOLS AND C-NITROSOANILINES AS POLYMERIZATION INHIBITORS | CROMPTON CORPORATION (US) | 2003-08-28 | — | — | WO | disclosed |
| US-20030155227-A1 | Nitrosophenols and C-nitrosoanilines as polymerization inhibitors | CROMPTON CORPORATION | 2003-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180361319-A1 | METHOD FOR IMPROVED REACTVE MONOMER PRODUCTION WITH MEMBRANE FILTRATION | PUF60, MAX, SAMM50 | LMNA 3213/4885RECQL 3482/4885NPC1 3917/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.